Health CarePharmaceuticals & Biotechnology
  • Price (GBX)38.63
  • Today's Change0.375 / 0.98%
  • Shares traded14.27k
  • 1 Year change-46.54%
  • Beta0.6567
Data delayed at least 20 minutes, as of Oct 25 2016 13:36 BST.
More ▼

Key statistics

On Tuesday, Vernalis PLC (VER:LSE) closed at 38.63, 24.60% above the 52 week low of 31.00 set on Jun 29, 2016.
52-week range
31.00Jun 29 201675.00Nov 03 2015
Markit short selling activity
Previous close38.25
Average volume132.02k
Shares outstanding526.20m
Free float520.48m
P/E (TTM)--
Market cap201.27m GBP
EPS (TTM)-0.0319 GBP
Data delayed at least 20 minutes, as of Oct 25 2016 13:36 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Vernalis PLC shares was Buy at 40.50 on 03 Oct 2016Read the full article

Board of Directors


Peter Fellner, Non-Executive Chairman


Ian Garland, Chief Executive Officer


David Mackney, Chief Financial Officer


Carol Ferguson, Non-Executive Director


Nigel Sheail, Non-Executive Director


Ian Gilham, Non-Executive Director


Lisa Schoenberg, Non-Executive Director

Investor Relations Contact

Advisors and Investor Contacts:

Capita Asset Services
The Registry
34 Beckenham Road
Kent BR3 4TU

ADR Depositary Bank
BNY Mellon
Shareowner Services
PO BOX 30170
College Station
TX 77842-3170
Pittsburg, USA

Company Secretary and Registered Office
100 Berkshire Place
Wharfedale Road
Winnersh, Berkshire
RG41 5RD, England

Chartered Accountants and Statutory Auditors
PricewaterhouseCoopers LLP
One Reading Central
23 Forbury Road
Reading, Berkshire

Covington & Burling LLP
265 Strand
London WC2R 1BH

Nominated Advisors and Broker
Canaccord Genuity Limited
88 Wood Street
London EC22V 7QR

Joint Broker
Shore Capital Stockbrokers Limited
Bond Street House
14 Clifford Street
London W1S 4JU

Public Relations
Brunswick Group LLP
16 Lincoln's Inn Fields
London WC2A 3ED

© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.